India Blocks Exports of Remdesivir and Its Active Pharmaceutical Ingredients

India now prohibits exports of antiviral medication Remdesivir, used to shorten COVID-19 recovery times, along with the drug's active pharmaceutical ingredients, effective with an April 11 trade notice. The products are under Indian Trade Classification Harmonized System Codes Ex 293499 and Ex 300490.